A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients

BACKGROUND: Iron deficiency anaemia is common in patients with chronic kidney disease, and intravenous iron is the preferred treatment for those on haemodialysis. The aim of this trial was to compare the efficacy and safety of iron isomaltoside 1000 (Monofer®) with iron sucrose (Venofer®) in haemodi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nephrol Dial Transplant
Auteurs principaux: Bhandari, Sunil, Kalra, Philip A., Kothari, Jatin, Ambühl, Patrice M., Christensen, Jeppe H., Essaian, Ashot M., Thomsen, Lars L., Macdougall, Iain C., Coyne, Daniel W.
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2015
Sujets:
Clinical Science
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4550440/
https://ncbi.nlm.nih.gov/pubmed/25925701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfv096
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires